What is the recommended dose of clindamycin (Clindamycin) for soft tissue infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dose of clindamycin for soft tissue infections in adults is 300-450 mg taken orally every 6-8 hours, or 600 mg administered intravenously every 8 hours for more severe infections, as per the guidelines from the Infectious Diseases Society of America 1.

Key Considerations

  • For children, the oral dosage is usually 20 mg/kg/day divided into 3 divided doses, while the intravenous dosage is 25-40 mg/kg/day divided into 3 divided doses 1.
  • Treatment duration generally ranges from 7-14 days, depending on the severity of the infection and clinical response.
  • Clindamycin is effective against many gram-positive organisms and anaerobes commonly found in soft tissue infections, and it has good tissue penetration.

Administration and Side Effects

  • When taking clindamycin orally, it should be taken with a full glass of water to prevent esophageal irritation.
  • Patients should complete the full course of antibiotics even if symptoms improve before completion to ensure eradication of the infection and prevent antibiotic resistance.
  • Common side effects include diarrhea, nausea, and abdominal pain, and patients should be advised to contact their healthcare provider if they develop severe diarrhea, as this could indicate Clostridioides difficile infection.

Evidence-Based Recommendations

  • The guidelines from the Infectious Diseases Society of America provide strong recommendations for the use of clindamycin in the treatment of soft tissue infections, based on high-quality evidence 1.
  • The recommended dosages and treatment durations are based on the severity of the infection and the patient's clinical response.

From the FDA Drug Label

Adults: Serious infections – 150 to 300 mg every 6 hours. More severe infections – 300 to 450 mg every 6 hours Pediatric Patients (for children who are able to swallow capsules): Serious infections – 8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections – 16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses.

The recommended dose of clindamycin for soft tissue infections is:

  • Adults: 150 to 300 mg every 6 hours for serious infections and 300 to 450 mg every 6 hours for more severe infections.
  • Pediatric Patients: 8 to 16 mg/kg/day divided into three or four equal doses for serious infections and 16 to 20 mg/kg/day divided into three or four equal doses for more severe infections 2.

From the Research

Clindamycin Dosage for Soft Tissue Infections

  • The recommended dose of clindamycin for soft tissue infections is not explicitly stated in the provided studies 3, 4, 5, 6, 7.
  • However, the studies suggest that clindamycin is effective in treating soft tissue infections, including those caused by Gram-positive organisms such as Staphylococcus aureus and streptococci 5, 6.
  • A retrospective survey of 15,019 patients treated with clindamycin for soft tissue infections found that the incidence of serious side effects was low, and the antibiotic was still considered useful for treating acute soft tissue infections 5.
  • Another study compared the efficacy of clindamycin and linezolid in treating necrotizing soft tissue infections and found that both antibiotics resulted in similar outcomes 4.
  • The choice of antibiotic and dosage may depend on various factors, including the severity of the infection, the causative organism, and the patient's medical history and condition.

Considerations for Clindamycin Use

  • Clindamycin has good activity against methicillin-susceptible Staphylococcus aureus, but resistance has been reported in some cases of methicillin-resistant S. aureus (MRSA) and streptococci 6.
  • The antibiotic has antitoxin activity, which may be beneficial in treating certain types of soft tissue infections 6.
  • Clindamycin is available in oral and parenteral formulations, which may facilitate early switch and early discharge protocols in clinical practice 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.